Cogent Biosciences, Inc. · NASDAQ:COGT
Kynam Capital Management, LP reported a 4.33% stake in Cogent Biosciences, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Kynam Capital Management, LP reported a 4.33% stake in Cogent Biosciences, Inc., 6,165,223 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 4.33%
- Shares
- 6,165,223
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Kynam Capital Management, LP | 4.33% | 6,165,223 |
| Kynam Capital Management GP, LLC | 4.33% | 6,165,223 |
| Yue Tang | 4.33% | 6,165,223 |
Source
Related
- Cogent Biosciences, Inc.
- Kynam Capital Management, LP
- Cogent Biosciences, Inc. shareholders
- Schedule 13G/A · Kynam Capital Management, LP · Nov 14, 2025
- Form 4 · Morris Arlene · Aug 31, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Robbins Andrew R · May 21, 2026